Acute Myopia and Angle Closure Glaucoma from Topiramate in a Seven-Year-Old: A Case Report and Review of the Literature
BMC Pediatrics 14:96, Rapoport, Y.,et al, 2014
Acute Myopia and Angle-Closure Glaucoma Induced by Topiramate
Neurol 61:1306, Boentert,M.,et al, 2003
Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001
Basilar Migraine Seizures, & Severe Epileptic EEG Abnormalities
Neurol 30:1122-1125, Panayiotopoulos,C.P., 1980
Sensorineural Hearing Loss: A Reversible Effect of Vigabatrin
Neurol 61:1020-1021, Papdeas,E.,et al, 2003
Sensorineural Hearing Loss:A Reversible Effect of Valproic Acid
Neurol 40:1896-1898, Armon,C.,et al, 1990
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Orthostatic Tremor
Neurol 86:458-464, Hassan, A.,et al, 2016
Diabetic Sensory and Motor Neuropathy
NEJM 374:1455-1464, Vinik, A.I.,et al, 2016
Use of Antiepileptic Drugs during Pregnancy and Risk of Spontaneous Abortion and Stillbirth: Population Based Cohort Study
BMJ 349:g5159, Bech, B.H.,et al, 2014
Weight Change Associated with Antiepileptic Drugs
JNNP 84:796-799, Pickrell, W.,et al, 2013
Early Child Development and Exposure to Antiepileptic Drugs Prenatally and Through Breastfeeding
JAMA Neurol 70:1367-1374, Veiby, G.,et al, 2013
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
NEJM 362:790-799, Glauser,T.A.,et al, 2010
Progressive Bone Deficit in Epilepsy
Neurol 70:170-176,166, Sheth,R.D.,et al, 2008
Bone Health in Young Women With Epilepsy After One Year of Antiepileptic Drug Monotherapy
Neurol 70:1586-1593, Pack,A.M.,et al, 2008
Tiagabine-Induced Myoclonic Status Epilepticus in a Nonepileptic Patient
Neurol 68:310, Vollmar,C. &Noachtar,S., 2007
The Syndrome of Transient Epileptic Amnesia
Ann Neurol 61:587-598, Butler,C.R.,et al, 2007
Weight Change and Antiepileptic Drugs. Health Issues and Criteria for Appropriate Selection of an Antiepileptic Agent.
The Neurologist 12:163-167, Biton,V., 2006
In Utero Antiepileptic Drug Exposure: Fetal Death and Malformations
Neurol 67:407-412, Meador,K.J.,et al, 2006
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter Gene ABCB1
NEJM 348:1442-1448,1480, Siddiqui,A.,et al, 2003
Lamotrigine for HIV-Associated Painful Sensory Neuropathies
Neurol 60:1508-1514, Simpson,D.M.,et al, 2003
Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003
A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003
Drug Points
BJM 327:905, Hadjikoutis,S.,et al, 2003
Antiepileptic Drug-Induced Bone Loss in Young Male Patients Who Have Seizures
Arch Neurol 59:781-786, Andress,D.L.,et al, 2002
Effect of Antiepileptic Drugs on Bone Density in Ambulatory Patients
Neurol 58:1348-1353, Farhat,G.,et al, 2002
Is There a Neurologist on the Flight?
Neurol 58:1739-1744,1717, Sirven,J.I.,et al, 2002
A Double-blind Placebo-controlled Trial of Topiramate Treatment for Essential Tremor
Neurol 59:132-134, Connor,G.S., 2002
Practice Patterns of Neurologists Regarding Bone and Mineral Effefcts of Antiepileptic Drug Therapy
Arch Neurol 58:1369-1374,1352, Valmadrid,C.,et al, 2001
Dysgeusia in Epileptic Patients Treated with Lamotrigine: Report of Three Cases
Neurol 57:1521, Avoni,P.,et al, 2001
Epilepsy, Broken Bones, and Fatty Stools
Lancet 355:1882, Drenth,J.P.H.,et al, 2000
Osteoporosis in Neurological Disorders
JNNP 68:543-549, Lloyd,M.E.,et al, 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Visual Field Constriction in Children Treated with Vigabatrin
Neurol 52:1713-1714,1537, Vanhatalo,S.&Paakkonen,L., 1999
A Randomized, Placebo-Controlled Study of Topiramate in Primary Generalized Tonic-Clonic Seizures
Neurol 52:1330-1337, Biton,V.,et al, 1999
Vigabatrin, a Gabaergic Antiepileptic Drug, Causes Concentric Visual Field Defects
Neurol 53:922-926, Kalviainen,R.,et al, 1999
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Severe Persistent Visual Field Constriction Associated with Vigabatrin
BMJ 14:180-181, Eke,T.,et al, 1997
Psychogenic Seizures:Ictal Characteristics and Diagnostic Pitfalls
Neurol 42:95-99, Leis,A.A.,et al, 1992
Management of Injuries Due to Chemical Weapons
BMJ 302:129-130, Murray,V.S.G.&Volans,G.N., 1991
Prenatal Prediction of Risk of the Fetal Hydantoin Syndrome
NEJM 322:1567-1572, Buehler,B.A.,et al, 1990
Valproate-Induced Coma with Ketosis and Carnitine Insufficiency
Arch Neurol 47:1131-1133, Triggs,W.J.,et al, 1990
Epileptic Amnesic Attacks:Benefit from Antiepileptic Drugs
Neurol 35:1188-1189, Pritchard,P.B.,et al, 1985
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980